December 16, 2021
“U.S. stocks rose slightly in early trading Thursday trading the Federal Reserve signaled it would be aggressive on tapering and sees three interest rate hikes in 2022. The Dow Jones Industrial Average climbed 137 points. The S&P 500 was flat and within… Continue Reading…
November 11, 2021
“EDITOR’S NOTE: The Associated Press reports that “the U.S. trade deficit hit an all-time high of $80.9 billion in September as American exports fell sharply while imports, even with supply chain problems at American ports, continue to climb.” This September… Continue Reading…
May 3, 2021
“The Dow Jones Industrial Average rose 300 points. The S&P 500 gained 0.6% and the Nasdaq Composite inched up 0.4%. Berkshire Hathaway shares rose 1% after Warren Buffett’s conglomerate reported a 20% surge in operating earnings and continued to buy back large… Continue Reading…
January 6, 2021
“Esperion (ESPR)… Overall, Esperion has 6 recent reviews on record, with a breakdown of 5 Buys and 1 Hold to give the stock a Strong Buy rating from the analyst consensus. The shares, trading at $27.16, have an average price target… Continue Reading…
January 5, 2021
“Esperion (ESPR)… Overall, Esperion has 6 recent reviews on record, with a breakdown of 5 Buys and 1 Hold to give the stock a Strong Buy rating from the analyst consensus. The shares, trading at $27.16, have an average price target… Continue Reading…
October 14, 2020
“Scorpio Tanker (STNG)… Overall, the Strong Buy analyst consensus rating here is unanimous, based on 4 recent Buy reviews. Scorpio Tanker is currently trading at $10.69, and its $28.75 average price target suggests a one-year upside of 168%… International Seaways… Continue Reading…
September 13, 2020
“Global soybean demand has been robust recently, with new American crop sales at record levels, said Jim Sutter, CEO of the U.S. Soybean Export Council. On Tuesday, prices of U.S. soybean futures rose to their highest levels since 2018 after the U.S. Department… Continue Reading…
August 17, 2020
“Shares of CureVac, the German biotech specializing in the messenger RNA technology that is the basis of many of the leading Covid-19 vaccine programs, is set to soar on its second day of trading. CureVac shares (ticker: CVAC) were up 42% in… Continue Reading…
Recent Comments